Advanced Treatments.Proven Technology. Better Outcomes.

In foot and ankle care, shockwave therapy may be considered for selected chronic tendon and soft-tissue disorders, including plantar heel pain and Achilles tendinopathy. Focused and radial technologies allow energy to be delivered according to the tissue and condition being treated. ESWT is performed without an incision and is commonly incorporated into a broader rehabilitation plan rather than used as a stand-alone solution.

STORZ describes EMTT as a non-invasive outpatient technology with deep penetration and high patient comfort, and it can be combined with shockwave therapy in selected treatment plans. In the United States, the device’s labeled indications should guide patient-facing claims; our physicians determine whether EMTT is appropriate after an individualized evaluation.

We take a conservative, evidence-informed approach: the specific product, regulatory classification, available human evidence, alternatives, risks, and realistic expectations are reviewed before treatment. Regenerative therapies should not be presented as guaranteed cures or substitutes for an accurate diagnosis and appropriate mechanical treatment. We offer regenerative options in the form of amnion injections as well as peptide supplementation therapy.

When appropriate, it can improve procedural precision by allowing the physician to visualize the target during aspiration or injection. Ultrasound complements—not replaces—X-ray, MRI, or CT when those studies are better suited to the clinical question.

The 980-nm REMY platform also has podiatric indications involving certain soft-tissue procedures and temporary increase of clear nail in patients with onychomycosis. Treatment selection depends on the diagnosis; laser therapy is not a replacement for correcting an underlying structural or mechanical problem when one is present.

As with every regenerative therapy, we review the specific product, its regulatory classification, the available evidence, alternatives, risks, and realistic expectations with you before treatment. Injections are typically combined with appropriate mechanical and rehabilitative care rather than used on their own.

Early published clinical work on human adipose tissue allograft for pedal fat-pad restoration is emerging, but patient selection and expectations remain important. Evaluation should also address the mechanical cause of overload and whether footwear, orthotics, offloading or other treatments are appropriate.

Much of the current research is preclinical, so peptide therapy is offered only after an individualized evaluation, with a clear discussion of the product’s regulatory status, the current evidence, alternatives, and realistic expectations. It is not a substitute for an accurate diagnosis or appropriate mechanical treatment.

Bioventus offers the StimRouter PNS platform for chronic peripheral nerve pain and a temporary StimTrial system to help assess candidacy. PNS may be considered for selected patients with persistent peripheral nerve pain after appropriate diagnostic evaluation and when more conservative treatment has not provided adequate relief.